Neurocrine Biosciences
NBIX
NBIX
231 hedge funds and large institutions have $3.86B invested in Neurocrine Biosciences in 2016 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 67 increasing their positions, 96 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
231
Holders Change
+19
Holders Change %
+8.96%
% of All Funds
6.17%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.19%
New
42
Increased
67
Reduced
96
Closed
22
Calls
$82.9M
Puts
$13.9M
Net Calls
+$69M
Net Calls Change
+$62.4M
Top Buyers
Top Sellers
| 1 |
VAM
1
Visium Asset Management
New York
|
$219K |
| 2 |
BFA
2
BlackRock Fund Advisors
San Francisco,
California
|
$88.4M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$42.4M |
| 4 |
O
4
OrbiMed
New York
|
$82.5M |
| 5 |
5
Invesco
Atlanta,
Georgia
|
$72.9M |
